Works by Hong, David


Results: 277
    1

    Research Priorities of Individuals and Families With Sex Chromosome Aneuploidies.

    Published in:
    American Journal of Medical Genetics. Part A, 2025, v. 197, n. 6, p. 1, doi. 10.1002/ajmg.a.63998
    By:
    • Carl, Alexandra;
    • Bothwell, Samantha;
    • Farah, Fathia;
    • Swenson, Karli;
    • Hong, David;
    • Prakash, Siddharth;
    • Strang, John;
    • Tartaglia, Nicole;
    • Raznahan, Armin;
    • Ross, Judith;
    • Rogol, Alan D.;
    • Dawczyk, Anna;
    • Hong, David S.;
    • Decker, Gail;
    • Cover, Ginnie;
    • Cohen, Lilian L.;
    • Davis, Shanlee;
    • Gerken, Steve;
    • Howell, Susan;
    • Bamba, Vaneeta
    Publication type:
    Article
    2
    3

    Association between new-onset hypothyroidism and clinical response in patients treated with tyrosine kinase inhibitor therapy in phase I clinical trials.

    Published in:
    2016
    By:
    • Bilen, Mehmet;
    • Patel, Amy;
    • Hess, Kenneth;
    • Munoz, Javier;
    • Busaidy, Naifa;
    • Wheler, Jennifer;
    • Janku, Filip;
    • Falchook, Gerald;
    • Hong, David;
    • Meric-Bernstam, Funda;
    • Habra, Mouhammed;
    • Naing, Aung;
    • Bilen, Mehmet Asim;
    • Hess, Kenneth R;
    • Busaidy, Naifa L;
    • Wheler, Jennifer J;
    • Falchook, Gerald S;
    • Hong, David S;
    • Habra, Mouhammed Amir
    Publication type:
    journal article
    4
    5
    6
    7
    8

    A Phase 1b/2 Study of the Bruton Tyrosine Kinase Inhibitor Ibrutinib and the PD-L1 Inhibitor Durvalumab in Patients with Pretreated Solid Tumors.

    Published in:
    Oncology, 2019, v. 97, n. 2, p. 102, doi. 10.1159/000500571
    By:
    • Hong, David;
    • Rasco, Drew;
    • Veeder, Michael;
    • Luke, Jason J.;
    • Chandler, Jason;
    • Balmanoukian, Ani;
    • George, Thomas J.;
    • Munster, Pamela;
    • Berlin, Jordan D.;
    • Gutierrez, Martin;
    • Mita, Alain;
    • Wakelee, Heather;
    • Samakoglu, Selda;
    • Guan, Shanhong;
    • Dimery, Isaiah;
    • Graef, Thorsten;
    • Borazanci, Erkut
    Publication type:
    Article
    9

    Post-Discharge Survival Outcomes of Patients with Advanced Cancer from the University of Texas MD Anderson Cancer Center Investigational Cancer Therapeutics (Phase I Trials) Inpatient Unit.

    Published in:
    Oncology, 2017, v. 92, n. 1, p. 14, doi. 10.1159/000449505
    By:
    • Kinahan, Holly;
    • Maiti, abhishek;
    • Hess, Kenneth;
    • Dempsey, Jennifer;
    • Beatty, Laura;
    • Baldwin, Sarah;
    • Hong, David S.;
    • Naing, aung;
    • Fu, Siqing;
    • Tsimberidou, apostolia M.;
    • Piha-Paul, Sarina;
    • Janku, Filip;
    • Karp, Daniel;
    • Reddy, Suresh;
    • Yennu, Sriram;
    • Epner, Daniel;
    • Bruera, Eduardo;
    • Meric-Bernstam, Funda;
    • Falchook, Gerald;
    • Subbiah, Vivek
    Publication type:
    Article
    10
    11

    Larotrectinib Treatment for Patients With TRK Fusion-Positive Salivary Gland Cancers.

    Published in:
    Oncologist, 2024, v. 29, n. 6, p. e779, doi. 10.1093/oncolo/oyac080
    By:
    • Le, Xiuning;
    • Baik, Christina;
    • Bauman, Jessica;
    • Gilbert, Jill;
    • Brose, Marcia S;
    • Grilley-Olson, Juneko E;
    • Patil, Tejas;
    • McDermott, Ray;
    • Raez, Luis E;
    • Johnson, Jennifer M;
    • Shen, Lin;
    • Tahara, Makoto;
    • Ho, Alan L;
    • Norenberg, Ricarda;
    • Dima, Laura;
    • Brega, Nicoletta;
    • Drilon, Alexander;
    • Hong, David S
    Publication type:
    Article
    12

    First-In-Human Phase I Study of Tinengotinib (TT-00420), a Multiple Kinase Inhibitor, as a Single Agent in Patients With Advanced Solid Tumors.

    Published in:
    Oncologist, 2024, v. 29, n. 4, p. e514, doi. 10.1093/oncolo/oyad338
    By:
    • Piha-Paul, Sarina A;
    • Xu, Binghe;
    • Dumbrava, Ecaterina E;
    • Fu, Siqing;
    • Karp, Daniel D;
    • Meric-Bernstam, Funda;
    • Hong, David S;
    • Rodon, Jordi A;
    • Tsimberidou, Apostolia M;
    • Raghav, Kanwal;
    • Ajani, Jaffer A;
    • Conley, Anthony P;
    • Mott, Frank;
    • Fan, Ying;
    • Fan, Jean;
    • Peng, Peng;
    • Wang, Hui;
    • Ni, Shumao;
    • Sun, Caixia;
    • Qiang, Xiaoyan
    Publication type:
    Article
    13

    Overview of Ocular Side Effects of Selinexor.

    Published in:
    Oncologist, 2021, v. 26, n. 7, p. 619, doi. 10.1002/onco.13756
    By:
    • Al‐Zubidi, Nagham;
    • Gombos, Dan S.;
    • Hong, David S.;
    • Subbiah, Vivek;
    • Fu, Siqing;
    • Ahnert, Jordi Rodon;
    • Piha‐Paul, Sarina A.;
    • Tsimberidou, Apostolia M.;
    • Karp, Daniel D.;
    • Bernstam, Funda Meric;
    • Naing, Aung
    Publication type:
    Article
    14
    15

    Comparative Effectiveness of an mTOR‐Based Systemic Therapy Regimen in Advanced, Metaplastic and Nonmetaplastic Triple‐Negative Breast Cancer.

    Published in:
    Oncologist, 2018, v. 23, n. 11, p. 1300, doi. 10.1634/theoncologist.2017-0498
    By:
    • Basho, Reva K.;
    • Yam, Clinton;
    • Gilcrease, Michael;
    • Murthy, Rashmi K.;
    • Helgason, Thorunn;
    • Karp, Daniel D.;
    • Meric‐Bernstam, Funda;
    • Hess, Kenneth R.;
    • Valero, Vicente;
    • Albarracin, Constance;
    • Litton, Jennifer K.;
    • Chavez‐MacGregor, Mariana;
    • Hong, David;
    • Kurzrock, Razelle;
    • Hortobagyi, Gabriel N.;
    • Janku, Filip;
    • Moulder, Stacy L.
    Publication type:
    Article
    16

    Clinical significance of residual ischaemia in acute myocardial infarction complicated by cardiogenic shock undergoing venoarterial–extracorporeal membrane oxygenation.

    Published in:
    European Heart Journal: Acute Cardiovascular Care, 2024, v. 13, n. 7, p. 525, doi. 10.1093/ehjacc/zuae058
    By:
    • Hong, David;
    • Choi, Ki Hong;
    • Ahn, Chul-Min;
    • Yu, Cheol Woong;
    • Park, Ik Hyun;
    • Jang, Woo Jin;
    • Kim, Hyun-Joong;
    • Bae, Jang-Whan;
    • Kwon, Sung Uk;
    • Lee, Hyun-Jong;
    • Lee, Wang Soo;
    • Jeong, Jin-Ok;
    • Park, Sang-Don;
    • Park, Taek Kyu;
    • Lee, Joo Myung;
    • Song, Young Bin;
    • Hahn, Joo-Yong;
    • Choi, Seung-Hyuk;
    • Gwon, Hyeon-Cheol;
    • Yang, Jeong Hoon
    Publication type:
    Article
    17

    A Phase 1, Randomized, Double‐Blind, Placebo‐Controlled, Single Ascending Dose Trial of AWZ1066S, an Anti‐Wolbachia Candidate Macrofilaricide.

    Published in:
    Clinical Pharmacology in Drug Development, 2024, v. 13, n. 9, p. 1071, doi. 10.1002/cpdd.1441
    By:
    • Devereux, Graham;
    • Bula, Marcin;
    • Tripp, Karen;
    • Fitzgerald, Richard;
    • Eraut, Nicola;
    • Alam, Muhammad Salman;
    • Moriyama, Tomoyuki;
    • Shinkyo, Raku;
    • Walker, Lauren;
    • Wang, Duolao;
    • Gusovsky, Fabian;
    • van der Velde, Jeannette;
    • Turner, Joseph D.;
    • Hong, Weiqian David;
    • O'Neill, Paul M.;
    • Taylor, Mark J.;
    • Ward, Stephen A.
    Publication type:
    Article
    18
    19

    Cancer-Related Internet Use and Its Association With Patient Decision Making and Trust in Physicians Among Patients in an Early Drug Development Clinic: A Questionnaire-Based Cross-Sectional Observational Study.

    Published in:
    2019
    By:
    • George, Goldy C;
    • Iwuanyanwu, Eucharia C;
    • Buford, Adrianna S;
    • Piha-Paul, Sarina A;
    • Subbiah, Vivek;
    • Fu, Siqing;
    • Karp, Daniel D;
    • Pant, Shubham;
    • Hinojosa, Christina O;
    • Hess, Kenneth R;
    • Cleeland, Charles S;
    • Bernstam, Elmer V;
    • Meric-Bernstam, Funda;
    • Hong, David S
    Publication type:
    journal article
    20
    21
    22
    23
    24
    25

    MET in ovarian cancer.

    Published in:
    Cell Cycle, 2014, v. 13, n. 8, p. 1220, doi. 10.4161/cc.28515
    By:
    • Tang, Chad;
    • Jardim, Denis L.;
    • Hong, David
    Publication type:
    Article
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42

    The Prevalence and Impact of Hyperglycemia and Hyperlipidemia in Patients With Advanced Cancer Receiving Combination Treatment With the Mammalian Target of Rapamycin Inhibitor Temsirolimus and Insulin Growth Factor-Receptor Antibody Cixutumumab.

    Published in:
    Oncologist, 2015, v. 20, n. 7, p. 737, doi. 10.1634/theoncologist.2015-0065
    By:
    • Busaidy, Naifa L.;
    • LoRusso, Patricia;
    • Lawhorn, Kristie;
    • Hess, Kenneth R.;
    • Habra, Mohammed Amir;
    • Fu, Siqing;
    • Hong, David S.;
    • Chen, Helen X.;
    • Doyle, Lawrence A.;
    • Kurzrock, Razelle;
    • Naing, Aung
    Publication type:
    Article
    43
    44
    45
    46
    47
    48

    Survival of patients with metastatic leiomyosarcoma: the MD Anderson Clinical Center for targeted therapy experience.

    Published in:
    Cancer Medicine, 2016, v. 5, n. 12, p. 3437, doi. 10.1002/cam4.956
    By:
    • Wang, Zhijie;
    • Shi, Naiyi;
    • Naing, Aung;
    • Janku, Filip;
    • Subbiah, Vivek;
    • Araujo, Dejka M.;
    • Patel, Shreyaskumar R.;
    • Ludwig, Joseph A.;
    • Ramondetta, Lois M.;
    • Levenback, Charles F.;
    • Ramirez, Pedro T.;
    • Piha‐Paul, Sarina A.;
    • Hong, David;
    • Karp, Daniel D.;
    • Tsimberidou, Apostolia M.;
    • Meric‐Bernstam, Funda;
    • Fu, Siqing
    Publication type:
    Article
    49
    50